Search

Search Results

• Book

  Challenging neuropathic pain syndromes : evaluation and evidence-based treatment

  Mitchell K. Freedman, Jeffrey A. Gehret, George W. Young, Leonard B. Kamen.

  Contents:
  Challenging Neuropathic Pain Syndromes, 1e 1. Piriformis Syndrome 2. Pain Syndromes Associated with Traumatic Brain Injury 3. Pain Syndromes Associated with Cerebrovascular Accidents 4. Pain Syndromes Associated with Spinal Cord Injury 5. Post Mastectomy Pain Syndrome 6. Lyme Related Pain Syndrome 7. Post-Thoracotomy Pain Syndrome 8. CRPS Introduction 9. CRPS Diagnostic Criteria 10. CRPS Medications 11. Chronic Pain and Centralization 12. CRPS
  Rehabilitation Treatment 13. CRPS
  Interventional Treatment 14. Phantom Limb Pain 15. Multiple Sclerosis associated pain syndromes 16. Chronic Pain and Centralization 17. Diabetic Neuropathic Pain Syndromes 18. HIV
  Related Pain Syndromes 19. Acute Herpes Zoster and Post-Herpetic Neuralgia 20. Oncological Pain Syndromes/Cancer Pain Syndromes/Malignancy and Paraneoplastic Pain Syndromes 21. Thoracic Outlet Syndrome 22. Parsonage-Turner Syndrome 23. Introduction 24. Pathophysiology of Pain 25. Screening, Measurement and Outcome Tools Utilized in the Management of Neuropathic 26. Pain Syndromes 27. HIV
  Related Pain Syndromes 28. Pathophysiology of Pain 29. Trigeminal Neuralgia and Facial Pain Syndromes 30. Pain Syndromes Associated with Cerebrovascular Accidents 31. CRPS Diagnostic Testing

  Digital Access

  Provider

  Version

  ScienceDirect

  2018

  ClinicalKey

  2018
  Get Shareable Link

  View Details
• Article

  Treatment of rheumatoid arthritis with levamisole. A controlled trial.

  Runge LA, Pinals RS, Lourie SH, Tomar RH.

  Arthritis Rheum. 1977 Nov-Dec;20(8):1445-8.

  Levamisole, an anthelminthic agent with immunostimulatory properties, was used in a double-blind, controlled therapeutic trial in rheumatoid arthritis. Patients received either levamisole 100 mg 4 days a week, or placebo, for a period of 4 months. Significant improvement in the treated group, as compared with the control group, was found in the number of tender and swollen joints, grip strength, range of joint motion, sedimentation rate, and C-reactive protein. On double-blind global evaluation by the examining physicians, 9 of 14 patients on levamisole and none of 13 on placebo were considered to have improved. Adverse effects did not differ in frequency between the two groups except for mild alteration in taste, which was more common with levamisole.

  Digital Access Access Options
  Get Shareable Link

  PubMed